September 24, 2024: Bar.on, a pioneering company in the non-alcoholic beverage sector, is pleased to announce its relocation to the Bio-Incubator in Leuven. Following a productive tenure at BlueChem in Antwerp, this move signifies a return to the city where Bar.on was established, positioning the company closer to vital research institutions and collaborators.
The new facility, located adjacent to Professor Kevin Verstrepen’s lab, provides Bar.on with enhanced opportunities for innovation and collaboration. The significantly larger lab space at the Bio-Incubator will facilitate expanded research and development activities, enabling the team to advance their product offerings and explore new avenues for growth.
While the relocation entails logistical challenges, including the careful packing and transportation of equipment, the Bar.on team is committed to ensuring a smooth transition. The excitement surrounding this new chapter is grounded in the potential it holds for advancing the company’s mission of delivering sustainable beverage options.
Bar.on’s investment campaign remains active, inviting interested investors to participate in the company’s growth journey. Prospective investors are encouraged to review the Key Investment Information Sheet and familiarize themselves with the associated risks prior to making any commitments.
This move to Leuven not only strengthens Bar.on’s operational capabilities but also reinforces its commitment to fostering closer ties within the local research community, setting the stage for future innovations in the sustainable beverage industry.
For more information, visit this link https://lnkd.in/eyCFssFr
Legal Disclaimer:
PressLink distributes this news content on an “as-is” basis, without any express or implied warranties of any kind. PressLink expressly disclaims all responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information presented in this article. Any complaints, copyright issues, or concerns regarding this article should be directed to the author.
Note:
This content is not authored by, nor does it reflect the endorsement of, PressLink, its advertisers, or any affiliated entities. For inquiries or corrections related to press releases, please contact PressLink directly.